Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
作者信息
Timmis A D, Richardson P J
出版信息
Scand J Clin Lab Invest Suppl. 1984;173:59-64.
PMID:6442003
Abstract
摘要
相似文献
1
Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.心力衰竭中的硝酸盐。病理生理机制与治疗应用。
Scand J Clin Lab Invest Suppl. 1984;173:59-64.
2
[Significance of nitrates in acute therapy of heart failure with and without lung edema].[硝酸盐在伴或不伴肺水肿的心力衰竭急性治疗中的意义]
Z Kardiol. 1985;74 Suppl 1:15-22.
3
[Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].肼屈嗪与硝酸异山梨酯治疗晚期心力衰竭（作者译）
Rev Med Chil. 1979 Oct;107(10):926-30.
4
[Vasodilators, oral nitrate derivatives and treatment of heart failure].[血管扩张剂、口服硝酸盐衍生物与心力衰竭的治疗]
Coeur Med Interne. 1976 Apr-Jun;15(2):139-46.
5
Circulatory improvement after hydralazine or isosorbide dinitrate administration in patients with heart failure. Effect on metabolic responses to submaximal exercise.
Am J Med. 1981 Oct;71(4):627-33. doi: 10.1016/0002-9343(81)90216-3.
6
[Vasodilator therapy in cardiac failure].
Nihon Rinsho. 1993 May;51(5):1276-80.
7
Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.急性心肌梗死心力衰竭患者血管扩张剂治疗的血流动力学和代谢效应
Jpn Circ J. 1984 Apr;48(4):380-7. doi: 10.1253/jcj.48.380.
8
Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.硝酸异山梨酯和肼苯哒嗪用于慢性心力衰竭的血管扩张剂治疗
Br Heart J. 1981 Apr;45(4):376-84. doi: 10.1136/hrt.45.4.376.
9
[Vasodilator therapy of congestive heart failure].[充血性心力衰竭的血管扩张剂治疗]
Dtsch Med Wochenschr. 1977 Sep 30;102(39):1388-94. doi: 10.1055/s-0028-1106733.
10
Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.肼屈嗪和硝酸异山梨酯：单独给药或联合给药时的中枢和局部血流动力学比较效应。
Circulation. 1981 Jan;63(1):102-9. doi: 10.1161/01.cir.63.1.102.
Zotero 插件